MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 541 SEK -4.25% Market Closed
Market Cap: 8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Net Income Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Net Income
kr294.3m
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
58%
AddLife AB
STO:ALIF B
Net Income
kr339m
CAGR 3-Years
-20%
CAGR 5-Years
16%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Net Income
-kr1.7B
CAGR 3-Years
-214%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Net Income
kr327m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
20%
G
Genovis AB
STO:GENO
Net Income
kr23.2m
CAGR 3-Years
41%
CAGR 5-Years
38%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Net Income
kr15.1m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Net Income?
Net Income
294.3m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Net Income amounts to 294.3m SEK.

What is MedCap AB (publ)'s Net Income growth rate?
Net Income CAGR 10Y
58%

Over the last year, the Net Income growth was 47%. The average annual Net Income growth rates for MedCap AB (publ) have been 38% over the past three years , 33% over the past five years , and 58% over the past ten years .

Back to Top